Lithium salt-containing pharmaceutical compositions
AssigneeScotia Holdings PLC
InventorDavid F. Horrobin
Life of this patent
Estimating the term…
Abstract
The invention provides pharmaceutical and disinfectant compositions containing lithium salts of C.sub.18-22 polyunsaturated fatty acids. The compositions may be used in the treatment of conditions responsive to lithium and/or polyunsaturated fatty acid therapy, in parenteral alimentation or food supplements or in surface disinfection to combat transmission of viral diseases.
Claims24
A pharmaceutical composition comprising a lithium salt of a C.sub.18-22 polyunsaturated fatty acid having at least two unsaturated carbon-carbon bonds together with at least one physiologically acceptable excipient or carrier material, with the proviso that where said composition is in a solid form adapted for oral administration into the stomach in the treatment of Alzheimer's disease said lithium salt therein is provided with a gastric juice resistant release delaying coating.
A disinfectant composition comprising a lithium salt of a C.sub.18-22 polyunsaturated fatty acid together with at least one carrier material.
Dependencies are inferred from the claim text.